PharmswellBio Co Ltd operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares PharmswellBio Co Ltd with three other companies in this sector in South Korea: Bioleaders Corp (2017 sales of 7.61 billion Korean Won [US$6.72 million] ), Nibec (6.30 billion Korean Won [US$5.57 million] ), and Enzychem Lifesciences Corp (26.13 billion Korean Won [US$23.08 million] of which 95% was Medicines).

Sales Analysis. During the year ended December of 2017, sales at PharmswellBio Co Ltd were 19.59 billion Korean Won (US$17.30 million). This is an increase of 24.6% versus 2016, when the company's sales were 15.72 billion Korean Won.